Sequential therapy with ranibizumab and dexamethasone intravitreal implant is better than dexamethasone monotherapy for macular oedema due to retinal vein occlusion
Purpose To evaluate the efficacy and safety of sequential therapy with ranibizumab followed by dexamethasone intravitreal implant compared with dexamethasone monotherapy for macular oedema (MO) secondary to retinal vein occlusion (RVO). Methods In this retrospective interventional study, the medical...
Main Authors: | Iu, L, Zhao, P, Yeung, I, Fung, N, Lee, J, Wong, R, Chong, V, Wong, I |
---|---|
格式: | Journal article |
語言: | English |
出版: |
BMJ Publishing Group
2014
|
相似書籍
-
Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
由: Xuemei Liang, et al.
出版: (2022-09-01) -
Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion and Resistant to Intravitreal Ranibizumab Injection
由: Ayşe Ergin, et al.
出版: (2022-12-01) -
A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
由: Alper Halil Bayat, et al.
出版: (2019-12-01) -
Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
由: Frederic Matonti, et al.
出版: (2012-10-01) -
Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
由: Tranos P, et al.
出版: (2024-11-01)